Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Highlights from the 2023 PDA Pharmaceutical Manufacturing & Quality Conference

Thursday, August 31, 2023

We have recently wrapped up PDA Pharmaceutical Manufacturing Quality Conference leaving behind a trail of insights innovations and connections that will reshape the future of pharmaceutical manufacturing

Epigenic Therapeutics Announces $32 Million in Series A Funding to Bring Breakthrough Epigenome Medicine to Clinical Development

Wednesday, August 30, 2023

Epigenic Therapeutics a leading biotechnology company dedicated to developing nextgeneration gene modulation therapy utilizing epigenome regulation to treat prevalent diseases today announced that it has raised million in Series A round of financing...

Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) in Egypt

Wednesday, August 30, 2023

Alvotech NASDAQ ALVO and Bioventure a wholly owned subsidiary of GlobalOne Healthcare Holding LLC today announced that the Egyptian Drug Authority EDA has approved the manufacturing and distribution of AVT adalimumab a biosimilar for Humira which is...

InxMed Receives Approval to Initiate Phase I Clinical Trial in China for OMTX705, a First-in-Class FAP-Targeting ADC

Wednesday, August 30, 2023

InxMed a clinicalstage biotechnology company dedicates on developing innovative therapies targeting drug resistance for hardtotreat solid tumorsannounced today the firstinclass ADC OMTX has obtained the IND Investigational New Drug approval from Chin...

Flomox® Fine Granules for children oral cephem antibiotic agent Launched in China

Thursday, August 31, 2023

Shionogi Co Ltd Head Office Osaka Japan Chief Executive Officer Isao Teshirogi PhD hereafter Shionogi today announced that Flomox Fine Granules for children hereafter this drug launched in China through our partner Beijing Huawei Pharmaceutical Co L...

Strides receives USFDA approval for Mycophenolate Mofetil for Oral Suspension

Thursday, August 31, 2023

Strides Pharma Science Limited Strides today announced that its step down wholly owned subsidiary Strides Pharma Global Pte Limited Singapore has received approval for Mycophenolate Mofetil for Oral Suspension USP mgmL from the United States Food D...

CStone Announces Registrational Trial of Sugemalimab in First-line Gastric or Gastroesophageal Junction Adenocarcinoma Met Primary Endpoint of Overall Survival

Tuesday, August 29, 2023

CStone Pharmaceuticals CStone HKEX a leading biopharmaceutical company focused on the research development and commercialization of innovative immunooncology therapies and precision medicines

XtalPi Inc. Unveils "XtalPi Intelligent Automation" and Announces New Automation Facility in Shanghai

Tuesday, August 29, 2023

XtalPi Inc XtalPi a leading technology platform company renowned for melding physicsbased computation artificial intelligence AI and robotics to advance the discovery and evolution of groundbreaking medicines and innovative materials unveiled its new...

Bionano Announces Second OEM Partner has Received China NMPA Approval for DNA Extraction and Labeling Products for IVD Use of OGM in Reproductive Health

Tuesday, August 29, 2023

Bionano Genomics Inc Nasdaq BNGO today announced that its Chinese original equipment manufacturing OEM partner Asmart MedTech Asmart an assisted reproductive technology company has obtained reagent class I registrations from Chinas National Medical P...

First participant treated at the highest dose level in Clarity’s theranostic prostate cancer trial

Monday, August 28, 2023

Clarity Pharmaceuticals ASX CU Clarity a clinical stage radiopharmaceutical company with a mission to develop nextgeneration products that improve treatment outcomes for children and adults with cancer is pleased to announce the dosing of the first p...